Myriad Genetics
MYGN
#7343
Rank
S$0.66 B
Marketcap
S$6.95
Share price
-2.80%
Change (1 day)
-17.40%
Change (1 year)

Earnings for Myriad Genetics (MYGN)

Earnings in 2026 (TTM): -S$0.5 Billion

According to Myriad Genetics's latest financial reports the company's current earnings are S$0.82 Billion. In 2025 the company made an earning of -S$0.5 Billion a decrease over its 2024 earnings that were of -S$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Myriad Genetics from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.5 Billion-0.96%
2025 -S$0.5 Billion218.91%
2024 -S$0.16 Billion-53.49%
2023 -S$0.34 Billion88.72%
2022 -S$0.18 Billion172.08%
2021 -S$65.15 Million
2019 -S$33.93 Million-175.14%
2018 S$45.15 M-70.81%
2017 S$0.15 B22.22%
2016 S$0.12 B-38.8%
2015 S$0.20 B-6.12%
2014 S$0.22 B-41.07%
2013 S$0.37 B46.67%
2012 S$0.25 B15.84%
2011 S$0.21 B17.6%
2010 S$0.18 B-15.96%
2009 S$0.22 B
2007 -S$53.77 Million40.96%
2006 -S$38.15 Million
2003 -S$44.3 Million34.8%
2002 -S$32.86 Million89.21%
2001 -S$17.37 Million3.93%
2000 -S$16.71 Million21.76%
1999 -S$13.73 Million-25.61%
1998 -S$18.45 Million38.83%
1997 -S$13.29 Million-24.26%
1996 -S$17.55 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Abbott Laboratories
ABT
S$9.31 B-1,969.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-S$0.24 Billion-52.79%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$56.32 M-111.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-S$45.11 Million-90.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
S$1.70 B-442.02%๐Ÿ‡บ๐Ÿ‡ธ USA